Asparaginase Activity Monitoring (AAM) in adult patients with Acute Lymphoblastic Leukemia (ALL)
Latest Information Update: 22 Mar 2022
At a glance
- Drugs Pegaspargase (Primary)
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Pharmacokinetics
- 10 Mar 2022 Status changed from recruiting to discontinued.
- 02 Sep 2021 New trial record